Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65.
Georgiadis A, Duran Y, Ribeiro J, Abelleira-Hervas L, Robbie SJ, Sünkel-Laing B, Fourali S, Gonzalez-Cordero A, Cristante E, Michaelides M, Bainbridge JWB, Smith AJ, Ali RR.
Georgiadis A, et al. Among authors: robbie sj.
Gene Ther. 2024 Sep;31(9-10):524. doi: 10.1038/s41434-024-00463-z.
Gene Ther. 2024.
PMID: 38997420
No abstract available.